UiPath Inc (NYSE:PATH) reported strong momentum in AI integration within their platform, highlighting a $200 million ARR contribution from AI-related products. The company has seen significant ...

UiPath Inc (NYSE: PATH) opened in the red this morning after the firm’s muted full-year outlook tempered its Q4 beat and announcement of a new $500 million share repurchase programme. To some, the ...

UiPath stock was falling early Thursday after its fourth-quarter earnings. A forecast of slower revenue growth in its current fiscal year punctured hopes the automation-software company will emerge as ...

UiPath, Inc. (NYSE:PATH) is one of the Best All-Time Low Stocks to Invest In Now. On February 23, UiPath, Inc. (NYSE:PATH), which is a leader in robotic process automation, launched new AI tools, ...

UiPath beat estimates on the top and bottom lines in the fourth quarter, reporting revenue of $481.11 million versus estimates of $464.49 million and adjusted earnings per share of 30 cents versus ...

With U.S. stock markets set to open in two hours, Hims & Hers Health Inc. (HIMS) was up 5.7% in pre-market trading, and Mosaic Co. (MOS) was up 4.4%.

UiPath stock was falling early Thursday after its fourth-quarter earnings. A forecast of slower revenue growth in its current fiscal year punctured hopes the automation-software company will emerge as ...

UiPath (PATH) is scheduled to report Q1 earnings on May 28, 2026. Analysts estimate EPS of $0.16 and quarterly revenue of $464.83M. In the most recent quarter (Q4), UiPath reported EPS of $0.30, ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Jonathan Groff will play his final performance on March 29, 2026. Matthew Morrison will play Bobby Darin from April 1 through April 19, 2026. Isa Briones begins performances as Connie Francis on April ...

Looking for what to see in theaters? Our feature, updated weekly, highlights our top recommendations for films currently in theaters, from new releases to restorations receiving a proper theatrical ...